Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026)
Boston Scientific's (BSX) quarterly Other Non-Current Assets came in at $44.4 billion in Q1 2026, up 2318.27% year-on-year from $1.8 billion in Q1 2025, and up 1.55% quarter-over-quarter from $43.7 billion in Q4 2025.
Boston Scientific (BSX) Other Non-Current Assets (2009 - 2026) Analysis & Trends
Boston Scientific has disclosed Other Non-Current Assets across 18 years of filings, most recently posting $44.4 billion for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $44.4 billion, up 2318.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $44.4 billion (up 2318.27% YoY), and the FY2025 annual result was $43.7 billion, up 10.86% from the prior year.
- Other Non-Current Assets came in at $44.4 billion for Q1 2026 at Boston Scientific, up from $43.7 billion in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $44.4 billion in Q1 2026 to a low of $1.4 billion in Q1 2022.
- The 5-year median for Other Non-Current Assets is $1.6 billion (2024), against an average of $17.4 billion.
- Across the five-year window, Other Non-Current Assets declined 19.78% in 2022 and surged 2579.5% in 2025, its largest moves.
- Boston Scientific's Other Non-Current Assets stood at $32.5 billion in 2022, then rose by 8.21% to $35.1 billion in 2023, then climbed by 12.12% to $39.4 billion in 2024, then climbed by 10.86% to $43.7 billion in 2025, then rose by 1.55% to $44.4 billion in 2026.
- The last three Other Non-Current Assets figures came in at $44.4 billion (Q1 2026), $43.7 billion (Q4 2025), and $42.7 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 828.89 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 1.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.35 Bn |
| Dec 31, 2025 | 43.67 Bn |
| Sep 30, 2025 | 42.71 Bn |
| Jun 30, 2025 | 41.56 Bn |
| Mar 31, 2025 | 1.83 Bn |
| Dec 31, 2024 | 39.40 Bn |
| Sep 30, 2024 | 1.64 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.60 Bn |
| Dec 31, 2023 | 35.14 Bn |
| Sep 30, 2023 | 1.61 Bn |
| Jun 30, 2023 | 1.60 Bn |
| Mar 31, 2023 | 1.48 Bn |
| Dec 31, 2022 | 32.47 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.57 Bn |
| Mar 31, 2022 | 1.38 Bn |
| Dec 31, 2021 | 1.41 Bn |
| Mar 31, 2021 | 1.71 Bn |
| Dec 31, 2020 | 1.13 Bn |